On Sept. 21, Mylan CEO Heather Bresch will appear at a U.S. | Figure 1
On Sept. 21, Mylan CEO Heather Bresch will appear at a U.S. congressional hearing over price increases for the EpiPen epinephrine autoinjector. The product now costs $600 for a pack of two EpiPens, up from $100 in 2007. "There is justified outrage from families and schools across the country struggling to afford the high cost of EpiPens,” said the panel co-chairman. "Our goal is to work together to ensure that critical medications, like the EpiPen, are accessible and affordable.” What would you ask Mylan or the FDA? We will compile the best questions on our blog and share them with media.
Why you should join Figure 1
- Share your knowledge with our global community of healthcare professionals
- Get help from experts in your field
- Learn from our library of real-world cases and quizzes